Therapeutic Potential of Clove Syzygium aromaticum in Managing Vaginal Candidiasis Caused by Candida albicans among the Odisha Population

Vulvovaginal candidiasis (VVC), commonly known as a vaginal yeast infection, is a widespread fungal condition caused primarily by Candida albicans, affecting women globally. It's becoming more prevalent in Odisha. Increasing antifungal resistance highlights the need for alternative treatments, particularly plant-based remedies. This study investigates the therapeutic potential of clove (Syzygium aromaticum) extract in managing vaginal candidiasis. Fifty vaginal swabs were collected from symptomatic women at IMS-SUM Hospital, Odisha. Candida albicans was isolated using SDA and CHROMagar Candida, and confirmed by ITS region PCR. Antifungal susceptibility was assessed by disk diffusion on Mueller-Hinton agar with 2% glucose and methylene blue. Syzygium aromaticum was sourced locally, and its phytochemicals were screened using qualitative methods. The antifungal activity of clove extract was evaluated at 50, 100, and 200 mg/mL concentrations using the well diffusion method to determine its efficacy against Candida albicans isolates. Of 50 samples, 38 (76%) tested positive for Candida albicans. Antifungal testing showed fluconazole resistance was observed in 32% of isolates. Clove extract showed antifungal activity with zones of 14.2 ± 1.1 mm at 50 mg/mL, 19.6 ± 1.4 mm at 100 mg/mL, and 25.3 ± 1.7 mm at 200 mg/mL, showing dose-dependent effects. The study confirms antifungal potential of Syzygium aromaticum against Candida albicans, due to bioactive compounds like eugenol. The extract showed effectiveness against fluconazole-resistant strains. Clove extract demonstrated strong antifungal activity against Candida albicans, offering a potential remedy for resistant vaginal candidiasis. Future research should examine in vivo effects and clinical trials for efficacy. Integrating Syzygium aromaticum into treatments could provide an effective approach for managing recurrent vaginal candidiasis.

Authors

Publication Details

Journal
International Research Journal of Multidisciplinary Scope
Published
2025-01-01
DOI
https://doi.org/10.47857/irjms.2025.v06i03.05340
Primary Topic
Essential Oils and Antimicrobial Activity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Potential of Clove Syzygium aromaticum in Managing Vaginal Candidiasis Caused by Candida albicans among the Odisha Population

Samapika Suhasini, Monali Priyadarsini Mishra, Gopal Krishna Purohit, Sushree Swagatika Subhadarsini et al.
International Research Journal of Multidisciplinary Scope
Essential Oils and Antimicrobial Activity
article

Therapeutic Potential of Clove Syzygium aromaticum in Managing Vaginal Candidiasis Caused by Candida albicans among the Odisha Population

Samapika Suhasini, Monali Priyadarsini Mishra, Gopal Krishna Purohit, Sushree Swagatika Subhadarsini, Lakshman Sahoo
article en

Abstract

Vulvovaginal candidiasis (VVC), commonly known as a vaginal yeast infection, is a widespread fungal condition caused primarily by Candida albicans, affecting women globally. It's becoming more prevalent in Odisha. Increasing antifungal resistance highlights the need for alternative treatments, particularly plant-based remedies. This study investigates the therapeutic potential of clove (Syzygium aromaticum) extract in managing vaginal candidiasis. Fifty vaginal swabs were collected from symptomatic women at IMS-SUM Hospital, Odisha. Candida albicans was isolated using SDA and CHROMagar Candida, and confirmed by ITS region PCR. Antifungal susceptibility was assessed by disk diffusion on Mueller-Hinton agar with 2% glucose and methylene blue. Syzygium aromaticum was sourced locally, and its phytochemicals were screened using qualitative methods. The antifungal activity of clove extract was evaluated at 50, 100, and 200 mg/mL concentrations using the well diffusion method to determine its efficacy against Candida albicans isolates. Of 50 samples, 38 (76%) tested positive for Candida albicans. Antifungal testing showed fluconazole resistance was observed in 32% of isolates. Clove extract showed antifungal activity with zones of 14.2 ± 1.1 mm at 50 mg/mL, 19.6 ± 1.4 mm at 100 mg/mL, and 25.3 ± 1.7 mm at 200 mg/mL, showing dose-dependent effects. The study confirms antifungal potential of Syzygium aromaticum against Candida albicans, due to bioactive compounds like eugenol. The extract showed effectiveness against fluconazole-resistant strains. Clove extract demonstrated strong antifungal activity against Candida albicans, offering a potential remedy for resistant vaginal candidiasis. Future research should examine in vivo effects and clinical trials for efficacy. Integrating Syzygium aromaticum into treatments could provide an effective approach for managing recurrent vaginal candidiasis.

International Research Journal of Multidisciplinary ScopeVol. 06(03)
Openalex Percentile: Top 76%
Essential Oils and Antimicrobial Activity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.